Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Silvia Anghel

Silvia Anghel has a unique combination of scientific research expertise and extensive industry experience in the field of in vitro diagnostics (IVD). Her distinguished background includes research conducted in prestigious laboratories across Canada and Switzerland, focusing on oncology, metabolism-related disorders including cardiovascular diseases and gastroenterology. She has more than 15 years of industry experience, managing projects related to the development, manufacturing, regulatory compliance and quality management of IVD devices. At Veranex, Silvia guides manufacturers through regulatory pathways and performance evaluation strategies, leveraging her comprehensive understanding of product lifecycles from development through commercialization. She provides strategic guidance in quality management system implementation, technical documentation development, and critical negotiations with Competent Authorities and Notified Bodies, making her an invaluable resource for companies navigating the complex IVD regulatory landscape.